Patients

Age (yr)

Gender

Tumor Location

GTV

(cm³)

ITV_all

(cm³)

ITV_MIP

(cm³)

ITV_AIP

(cm³)

ITV_2phases

(cm³)

PVD_MIP

PVD_AIP

PVD_2phase

1

81

male

LML

4.82

9.23

8.49

6.81

7.55

−0.08

−0.26

−0.18

2

73

male

RML

4.05

9.61

8.67

6.49

4.60

−0.10

−0.32

−0.52

3

75

female

RML

2.52

7.11

6.18

6.26

4.52

−0.13

−0.12

−0.36

4

58

female

RLL

7.26

18.09

16.23

16.33

13.49

−0.10

−0.10

−0.25

5

78

male

RML

7.84

17.59

15.08

15.74

13.09

−0.14

−0.10

−0.26

6

65

male

RML

7.05

15.01

14.00

13.48

11.76

−0.07

−0.10

−0.22

7

52

female

RLL

7.11

25.53

22.81

22.18

19.42

−0.11

−0.13

−0.24

8

59

female

RML

10.91

23.93

22.63

20.45

17.79

−0.05

−0.15

−0.26

9

55

female

RML

2.59

7.26

6.75

5.88

4.89

−0.07

−0.19

−0.33

10

60

male

LML

4.11

13.30

12.61

11.95

11.23

−0.05

−0.10

−0.16

11

83

male

RLL

4.80

18.46

16.51

16.85

14.87

−0.11

−0.09

−0.19

12

52

male

LUL

6.94

21.62

20.58

19.89

17.99

−0.05

−0.08

−0.17

13

47

female

RUL

3.71

9.43

8.76

8.85

7.77

−0.07

−0.06

−0.18

14

75

male

RML

12.78

37.16

34.40

34.59

28.83

−0.07

−0.07

−0.22